Nesa Medtech receives CDSCO Manufacturing License, Marking a Milestone in Next Generation Uterine Fibroid Treatment
Bangalore (Karnataka) [India], July 25: Nesa Medtech, a leading medical device startup in women’s health, has announced its flagship product, GYIDE, received a manufacturing license from CDSCO (Central Drugs Standard Control Organization). This approval marks a significant milestone for the company able to offer scarless treatment for uterine fibroids compared to the existing invasive solutions. […]
Continue Reading